Catalyst
Slingshot members are tracking this event:
Clovis' (CLVS) European Marketing Authorization Application (MAA) Submission for Rucaparib in ADHD Planned for Q4 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLVS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 03, 2016
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle&ID=2219461
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Marketing Authorization Application, Rucaparib, Adhd
